These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33869033)

  • 1. Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
    Behrooz AB; Syahir A
    Front Oncol; 2021; 11():642719. PubMed ID: 33869033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
    Daisy Precilla S; Biswas I; Kuduvalli SS; Anitha TS
    Cell Signal; 2022 Jul; 95():110350. PubMed ID: 35525406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
    Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
    Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging targets for glioblastoma stem cell therapy.
    Safa AR; Saadatzadeh MR; Cohen-Gadol AA; Pollok KE; Bijangi-Vishehsaraei K
    J Biomed Res; 2016 Jan; 30(1):19-31. PubMed ID: 26616589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma.
    Shevchenko V; Arnotskaya N; Zaitsev S; Sharma A; Sharma HS; Bryukhovetskiy A; Pak O; Khotimchenko Y; Bryukhovetskiy I
    Int Rev Neurobiol; 2020; 151():185-200. PubMed ID: 32448607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review.
    Shahcheraghi SH; Tchokonte-Nana V; Lotfi M; Lotfi M; Ghorbani A; Sadeghnia HR
    Curr Pharm Des; 2020; 26(15):1729-1741. PubMed ID: 32003685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells.
    Manoranjan B; Chokshi C; Venugopal C; Subapanditha M; Savage N; Tatari N; Provias JP; Murty NK; Moffat J; Doble BW; Singh SK
    Oncogene; 2020 Feb; 39(7):1590-1599. PubMed ID: 31695152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astrocyte Elevated Gene-1 Regulates β-Catenin Signaling to Maintain Glioma Stem-like Stemness and Self-Renewal.
    Hu B; Emdad L; Kegelman TP; Shen XN; Das SK; Sarkar D; Fisher PB
    Mol Cancer Res; 2017 Feb; 15(2):225-233. PubMed ID: 27903708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLD1 is a key player in cancer stemness and chemoresistance: Therapeutic targeting of cross-talk between the PI3K/Akt and Wnt/β-catenin pathways.
    Lim SH; Lee H; Lee HJ; Kim K; Choi J; Han JM; Min DS
    Exp Mol Med; 2024 Jul; ():. PubMed ID: 38945955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ionizing Radiation Induces Resistant Glioblastoma Stem-Like Cells by Promoting Autophagy via the Wnt/β-Catenin Pathway.
    Tsai CY; Ko HJ; Huang CF; Lin CY; Chiou SJ; Su YF; Lieu AS; Loh JK; Kwan AL; Chuang TH; Hong YR
    Life (Basel); 2021 May; 11(5):. PubMed ID: 34069945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
    Fargeas CA; Lorico A; Corbeil D
    Front Oncol; 2021; 11():712358. PubMed ID: 34476215
    [No Abstract]   [Full Text] [Related]  

  • 14. iPSC-Derived Glioblastoma Cells Have Enhanced Stemness Wnt/β-Catenin Activity Which Is Negatively Regulated by Wnt Antagonist sFRP4.
    Yasmin IA; Dharmarajan A; Warrier S
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia.
    Evangelisti C; Chiarini F; Cappellini A; Paganelli F; Fini M; Santi S; Martelli AM; Neri LM; Evangelisti C
    J Cell Physiol; 2020 Jun; 235(6):5413-5428. PubMed ID: 31904116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/β-catenin signaling pathway.
    Shi L; Fei X; Wang Z; You Y
    In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1047-55. PubMed ID: 26170223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between β-Catenin and CCL2 Drives Migration of Monocytes towards Glioblastoma Cells.
    Aretz P; Maciaczyk D; Yusuf S; Sorg RV; Hänggi D; Liu H; Liu H; Dakal TC; Sharma A; Bethanabatla R; Neumann S; Maciaczyk J
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Autophagy Status of Cancer Stem Cells in Gliobastoma Multiforme: From Cancer Promotion to Therapeutic Strategies.
    Ryskalin L; Gaglione A; Limanaqi F; Biagioni F; Familiari P; Frati A; Esposito V; Fornai F
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31387280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma Multiforme Stem Cell Cycle Arrest by Alkylaminophenol Through the Modulation of EGFR and CSC Signaling Pathways.
    Doan P; Musa A; Murugesan A; Sipilä V; Candeias NR; Emmert-Streib F; Ruusuvuori P; Granberg K; Yli-Harja O; Kandhavelu M
    Cells; 2020 Mar; 9(3):. PubMed ID: 32164385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posaconazole inhibits the stemness of cancer stem-like cells by inducing autophagy and suppressing the Wnt/β-catenin/survivin signaling pathway in glioblastoma.
    Wang H; Tan Y; Jia H; Liu D; Liu R
    Front Pharmacol; 2022; 13():905082. PubMed ID: 36034873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.